The Technical Analyst
Select Language :
Edesa Biotech Inc [EDSA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Edesa Biotech Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Edesa Biotech Inc is listed at the  Exchange

-5.80% $4.19

America/New_York / 28 mar 2024 @ 16:00


Edesa Biotech Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 13.30 mill
EPS: -20.16
P/E: -0.210
Earnings Date: May 08, 2024
SharesOutstanding: 3.17 mill
Avg Daily Volume: 0.0147 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.210 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.04x
Company: PE -0.210 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.263
(-93.72%) $-3.93
Date: 2024-03-28
Expected Trading Range (DAY)

$ 3.76 - 4.54

( +/- 9.40%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-25 Nijhawan Pardeep Buy 5 000 Common Shares
2024-03-01 Nijhawan Pardeep Buy 2 765 Common Shares
2024-02-01 Nijhawan Pardeep Buy 2 978 Common Shares
2024-01-08 Nijhawan Pardeep Buy 2 908 Common Shares
2023-08-04 Lemieux Stephen Buy 17 400 Common Shares
INSIDER POWER
75.70
Last 96 transactions
Buy: 2 353 687 | Sell: 309 119

Forecast: 16:00 - $4.19

Live Trading Signals (every 1 min)

Forecast 1: 15:53 - $4.12
Forecast 2: 16:00 - $4.19
Forecast 3: 16:00 - $4.19
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $4.19 (-5.80% )
Volume 0.0101 mill
Avg. Vol. 0.0147 mill
% of Avg. Vol 68.42 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Edesa Biotech Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Edesa Biotech Inc

RSI

Last 10 Buy & Sell Signals For EDSA

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Edesa Biotech Inc

EDSA

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

Last 10 Buy Signals

Date Signal @
PEPECOINUSDMar 29 - 02:245.83
VRXUSDMar 29 - 02:1960.44
^N300Mar 29 - 02:00594.52
CBKUSDMar 29 - 02:151.087
ORCAUSDMar 29 - 02:153.83
TRXUSDMar 29 - 02:10$0.120
BADGERUSDMar 29 - 02:117.11
INDEXUSDMar 29 - 02:085.97
FUMOUSDMar 29 - 02:109 998.30
FTNUSDMar 29 - 02:101.819

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.